RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
LivaNova Stock

LivaNova Revenue 2024

LivaNova Revenue

1.27 B USD

Ticker

LIVN

ISIN

GB00BYMT0J19

WKN

A14156

In 2024, LivaNova's sales reached 1.27 B USD, a 10.27% difference from the 1.15 B USD sales recorded in the previous year.

The LivaNova Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2028e1.551,55
2027e1.4353,93
2026e1.4154,62
2025e1.3457,56
2024e1.2760,63
20231.1566,86
20221.0269,21
20211.0468,19
20200.9363,66
20191.0866,76
20181.1166,35
20171.0164,39
20160.9657,99
20150.4264,11
20140.2990,63
20130.2890,30
20120.2591,39
20110.2291,00
20100.1987,91
20090.1787,54
20080.1486,04
20070.1282,60
20060.1386,06
20050.1287,18
20040.184,85

LivaNova Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into LivaNova, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by LivaNova from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects LivaNova’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of LivaNova. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into LivaNova’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing LivaNova’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on LivaNova’s growth potential.

LivaNova Revenue, EBIT and net profit per share

DateLivaNova RevenueLivaNova EBITLivaNova Net Income
2028e1.5 B undefined368.53 M undefined274.16 M undefined
2027e1.43 B undefined323.8 M undefined241.48 M undefined
2026e1.41 B undefined297.33 M undefined225.66 M undefined
2025e1.34 B undefined269.52 M undefined205.09 M undefined
2024e1.27 B undefined231.62 M undefined186.97 M undefined
20231.15 B undefined56.95 M undefined17.55 M undefined
20221.02 B undefined81.56 M undefined-86.25 M undefined
20211.04 B undefined47 M undefined-135.82 M undefined
2020934.24 M undefined-54.23 M undefined-348.82 M undefined
20191.08 B undefined58.87 M undefined-157.64 M undefined
20181.11 B undefined88.84 M undefined-189.4 M undefined
20171.01 B undefined126.99 M undefined-25.09 M undefined
2016964.86 M undefined88.93 M undefined-62.79 M undefined
2015415.71 M undefined41.53 M undefined-29.61 M undefined
2014291.56 M undefined97.34 M undefined57.85 M undefined
2013282.01 M undefined87.46 M undefined54.89 M undefined
2012254.32 M undefined78.35 M undefined46.36 M undefined
2011218.5 M undefined60.94 M undefined36.08 M undefined
2010190.46 M undefined49.19 M undefined46.73 M undefined
2009167.78 M undefined36.86 M undefined78.45 M undefined
2008143.6 M undefined18.99 M undefined26.72 M undefined
2007121.23 M undefined-8.23 M undefined-10.34 M undefined
2006130.97 M undefined-49.53 M undefined-51.18 M undefined
2005123.44 M undefined-59.23 M undefined-59.07 M undefined
2004103.44 M undefined-19.3 M undefined-18.61 M undefined

LivaNova stock margins

The LivaNova margin analysis displays the gross margin, EBIT margin, as well as the profit margin of LivaNova. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for LivaNova.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the LivaNova's sales revenue. A higher gross margin percentage indicates that the LivaNova retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the LivaNova's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the LivaNova's total revenue generated. When comparing the revenue margin year over year, investors can gauge the LivaNova's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the LivaNova. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the LivaNova's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

LivaNova Margin History

LivaNova Gross marginLivaNova Profit marginLivaNova EBIT marginLivaNova Profit margin
2028e66.86 %24.63 %18.33 %
2027e66.86 %22.64 %16.89 %
2026e66.86 %21.06 %15.98 %
2025e66.86 %20.11 %15.3 %
2024e66.86 %18.21 %14.7 %
202366.86 %4.94 %1.52 %
202269.21 %7.98 %-8.44 %
202168.19 %4.54 %-13.12 %
202063.66 %-5.8 %-37.34 %
201966.76 %5.43 %-14.54 %
201866.35 %8.03 %-17.11 %
201764.39 %12.54 %-2.48 %
201657.99 %9.22 %-6.51 %
201564.11 %9.99 %-7.12 %
201490.63 %33.39 %19.84 %
201390.3 %31.01 %19.46 %
201291.39 %30.81 %18.23 %
201191 %27.89 %16.51 %
201087.91 %25.83 %24.53 %
200987.54 %21.97 %46.76 %
200886.04 %13.22 %18.61 %
200782.6 %-6.79 %-8.53 %
200686.06 %-37.82 %-39.08 %
200587.18 %-47.98 %-47.85 %
200484.85 %-18.65 %-17.99 %

LivaNova Aktienanalyse

What does LivaNova do?

LivaNova PLC is a global medical technology company specializing in the development and manufacturing of devices and therapies for cardiovascular diseases, epilepsy, and brain disorders. The company was founded in 2015 through the merger of Sorin Group and Cyberonics, and in 2019, a legal dispute resulted in the agreement to make compensation payments. The company is divided into three main divisions: cardiac surgery, neuromodulation, and cardiac rhythm management. Each division offers different products for their target markets. The cardiac surgery division provides devices for surgical treatment of cardiovascular diseases, such as heart valve repair and replacement systems, cardioplegia systems for heart cooling during surgery, and mechanical heart support systems for patients with severe heart failure. Neuromodulation specializes in the treatment of epilepsy, brain injuries, and psychiatric disorders. The division offers both implantable devices directly implanted in the brain and external devices that use magnetic fields to influence brain activity. The cardiac rhythm management division focuses on the treatment of heart rhythm disorders and offers pacemakers, implantable cardioverter-defibrillators (ICDs), catheters, and ablation systems to correct electrical changes in the heart. LivaNova is headquartered in London and has manufacturing facilities in North America, Europe, and Asia. The company works closely with clinical partners worldwide to understand the medical needs of patients and develop new products and therapies aimed at improving patients' lives. Overall, LivaNova's business model is centered around commitment to innovation, production, and global presence. The company aims to improve the quality of healthcare and provide better therapies and devices to patients worldwide. The focus of product development is often a balance of effectiveness, safety, and patient comfort. The answer is: LivaNova is a global medical technology company specializing in the development and manufacturing of devices and therapies for cardiovascular diseases, epilepsy, and brain disorders. LivaNova ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding LivaNova's Sales Figures

The sales figures of LivaNova originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing LivaNova’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize LivaNova's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in LivaNova’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about LivaNova stock

How much revenue did LivaNova generate this year?

LivaNova has achieved a revenue of 1.27 B USD this year.

How much was the turnover of the company LivaNova compared to the previous year?

The revenue of LivaNova has increased by 10.27% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of LivaNova?

The revenue of LivaNova is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of LivaNova measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of LivaNova so important for investors?

The revenue of LivaNova is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does LivaNova pay?

Over the past 12 months, LivaNova paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, LivaNova is expected to pay a dividend of 0 USD.

What is the dividend yield of LivaNova?

The current dividend yield of LivaNova is .

When does LivaNova pay dividends?

LivaNova pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of LivaNova?

LivaNova paid dividends every year for the past 0 years.

What is the dividend of LivaNova?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is LivaNova located?

LivaNova is assigned to the 'Health' sector.

Wann musste ich die Aktien von LivaNova kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of LivaNova from 11/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/16/2024.

When did LivaNova pay the last dividend?

The last dividend was paid out on 11/16/2024.

What was the dividend of LivaNova in the year 2023?

In the year 2023, LivaNova distributed 0 USD as dividends.

In which currency does LivaNova pay out the dividend?

The dividends of LivaNova are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The LivaNova stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von LivaNova

Our stock analysis for LivaNova Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of LivaNova Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.